Track how companies discuss tariffs and trade policies in their earnings calls, and understand their impact across different industries and regions.
Based on the regulatory environment as we know it to-date, we believe our annualized exposure to tariffs before mitigating actions is approximately 2% of sales or 3% of cost of goods sold.
Preliminary estimate of tariff-related costs is expected to increase our annual expenses by approximately $150 million to $200 million.
BBSI has minimal to no direct exposure to tariffs. However, we have indirect exposure if this causes our clients to reduce or increase their workforce.
Recently enacted tariffs are currently causing some customers to delay shipments could impact future end market demand and has also resulted in an increase in certain costs.
We haven't seen a big impact of related to the tariffs in the U.S.
Our initial estimates are that U.S. policy changes to federal research funding, lower China stimulus funding release and some temporary revenue impact of new China tariffs on revenue will amount to an approximately $100 million gross headwind to our organic fiscal year 2025 revenues.
At this time, we estimate that the impact to Amphastar under the current tariff situation is an increasing cost of about $500,000 per quarter.
We believe ADMA is uniquely insulated from the tariff and trade volatility potentially affecting our multinational competitors.
we're working very closely with our customers to mitigate impacts of tariff actions
Although we do not anticipate current tariff announcements to have a direct impact on our ability to manufacture and sell our products and services to our global base of customers; unique geopolitical and trade dynamics have created near-term order hesitation in certain capital equipment markets.